LAG3 as a marker of immune activation in esophageal squamous carcinoma treated with concurrent chemoradiotherapy
Y. Zhang(Tianjin Medical University Cancer Institute and Hospital), Qingsong Pang(Chinese Academy of Medical Sciences & Peking Union Medical College), Ziyang Zhou(Tongji University), Hui Huang(Tianjin Medical University Cancer Institute and Hospital), Zhen Peng(Chifeng University), Xi Chen(117th Hospital of People's Liberation Army), Ping Wang(Netherlands Heart Registration), Jiarui Zhang(Chifeng University), Fang Fang(Montana State University), Jiacheng Li(Jiamusi University), Fanhao Kong(Tianjin Medical University Cancer Institute and Hospital), Gang Zhao(Soochow University), Tian Zhang(The University of Texas Southwestern Medical Center), Zhoubo Guo(Tianjin Medical University Cancer Institute and Hospital), Jun Wang(Shandong University), Fangdong Zhao(Tianjin Medical University Cancer Institute and Hospital), Wencheng Zhang(Tianjin Medical University Cancer Institute and Hospital), Yuanyuan Rui(Tianjin Medical University Cancer Institute and Hospital)
Cited by 2
Related Papers
Integration of External Signaling Pathways with the Core Transcriptional Network in Embryonic Stem Cells
|Cell|2008|2.6k
Neoadjuvant Chemoradiotherapy Followed by Surgery Versus Surgery Alone for Locally Advanced Squamous Cell Carcinoma of the Esophagus (NEOCRTEC5010): A Phase III Multicenter, Randomized, Open-Label Clinical Trial
|Journal of Clinical Oncology|2018|976
Tumor-associated macrophages-derived exosomes promote the migration of gastric cancer cells by transfer of functional Apolipoprotein E
|Cell Death and Disease|2018|390